Close Menu
TIMES24H – International Breaking News
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    TIMES24H – International Breaking News
    • Hot!
      • Vietnam
      • Asia
      • Video
    • World
      • PR Newswire
      • Media OutReach Newswire
      • GLOBENEWSWIRE
    • Business
    • Life
      • Lifestyle
      • Recipes
      • Fashion
    • Sport
    • Tech
      • Gadgets
    Media Outreach Newswire
    TIMES24H – International Breaking News
    Home»Breaking News»Novavax Covid-19 vaccine is 93% effective against variants in trial | World News
    Breaking News

    Novavax Covid-19 vaccine is 93% effective against variants in trial | World News

    Mike HarrisonBy Mike HarrisonJune 14, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Novavax Inc.’s Covid-19 vaccine candidate showed strong efficacy against the coronavirus, including mutated variants, in a large trial.

    Bloomberg |

    UPDATED ON JUN 14, 2021 04:52 PM IST

    Novavax Inc.’s Covid-19 vaccine candidate showed strong efficacy against the coronavirus, including mutated variants, in a large trial.

    The shot was 90% effective at preventing symptomatic Covid and 100% effective at preventing moderate and severe symptoms, the U.S. biotech firm said Monday. The shot was 93% effective against variants of concern, it said.

    “Novavax is one step closer to addressing the critical and persistent global public health need for additional Covid-19 vaccines,” Chief Executive Officer Stanley C. Erck said in a statement. “Novavax continues to work with a sense of urgency to complete our regulatory submissions and deliver this vaccine, built on a well understood and proven platform, to a world that is still in great need of vaccines.”

    Novavax shares rose 8.5% in premarket U.S. trading.

    The company previously said it wouldn’t file for vaccine authorization in the U.S. and Europe until the third quarter of the year. Novavax says it’s on track to reach manufacturing capacity of 100 million doses per month by the end of the third quarter and 150 million per month by the end of 2021.

    The company’s phase 3 trial included almost 30,000 participants in the U.S. and Mexico.

    Get our daily newsletter

    Thank you for subscribing to our daily newsletter.

    Close

    World News

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    AI Riser Vietnam 2026

    AI Riser Vietnam 2026: Google showcases 10 Vietnamese-built AI projects at Ho Chi Minh City forum

    October 8, 2026

    CCTV+: Xi presents the main directions for developing new quality productive forces

    January 3, 2026
    Hai Sau Sau (266) Partners with Samsung to Drive “One Samsung” Strategy in Vietnam

    Hai Sau Sau (266) Partners with Samsung to Drive “One Samsung” Strategy in Vietnam

    November 13, 2025
    Leave A Reply Cancel Reply

    Latest News
    etisalat achieves record 9M 2026 performance as consolidated net profit rises 46% YoY to AED 17.2 billion

    etisalat achieves record 9M 2026 performance as consolidated net profit rises 46% YoY to AED 17.2 billion

    October 27, 2026
    vivo x Kolder Creative: New Smartphone Filmmaking Masterclass Featuring vivo X500 Pro Max

    vivo x Kolder Creative: New Smartphone Filmmaking Masterclass Featuring vivo X500 Pro Max

    October 27, 2026
    Datasite Connects Live Deal Data to Emma Legal’s AI Workspace

    Datasite Connects Live Deal Data to Emma Legal’s AI Workspace

    October 27, 2026
    Guidewire Delivers the Open, Secure, and Complete Core Platform for Agentic Insurance

    Guidewire Delivers the Open, Secure, and Complete Core Platform for Agentic Insurance

    October 27, 2026
    DMCA.com Protection Status
    Facebook X (Twitter) Instagram Pinterest
    TIMES24H
    Global News · Trusted Information · Clear Perspectives
    TIMES24H is a global news platform delivering timely, reliable, and insightful coverage across technology, business, lifestyle, and current affairs. Our mission is to provide readers with clear perspectives and trusted information to navigate a fast-changing world.
    News & Editorial: news@times24h.com
    © 2026 TIMES24H . All rights reserved.

    Type above and press Enter to search. Press Esc to cancel.